Moderna, Inc.
MRNA
$49.04
-$0.99-1.98%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 4.86% | 20.75% | -40.11% | 50.52% | 43.75% |
| Total Depreciation and Amortization | 22.40% | 13.76% | -37.16% | -60.61% | -66.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.36% | 12.33% | 190.10% | -46.16% | -24.76% |
| Change in Net Operating Assets | 385.67% | 398.72% | 155.69% | -142.63% | -118.44% |
| Cash from Operations | 51.97% | 37.65% | 38.32% | 16.78% | -5.90% |
| Capital Expenditure | 85.91% | 81.73% | 9.88% | -7.45% | -23.04% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -63.86% | -28.73% | -21.08% | -17.67% | 13.86% |
| Cash from Investing | -55.49% | -0.15% | -25.38% | -26.86% | 10.72% |
| Total Debt Issued | 29,800.00% | -- | -200.00% | -200.00% | -- |
| Total Debt Repaid | -100.00% | -80.00% | 87.10% | 93.12% | 96.34% |
| Issuance of Common Stock | -5.56% | -46.97% | -57.14% | -47.83% | 1.89% |
| Repurchase of Common Stock | -200.00% | -- | -- | -- | 99.84% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,217.39% | 958.93% | 118.00% | 117.65% | 105.60% |
| Foreign Exchange rate Adjustments | -- | -- | 0.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 163.60% | 166.87% | 60.72% | 10.66% | 67.99% |